Death tells us what happened, not what’s happening. Medicine has spent decades obsessing over the final scene while the real drama unfolds in the second act. If we’re serious about extending healthspan, we’ve got to start measuring the Aneuploid Pivot.

This Pivot is the specific window where a tissue’s Spindle Assembly Checkpoint (SAC) degrades just enough to allow a sub-lethal wave of chromosomal instability. This isn’t cancer; it’s a quiet, systemic erosion of genomic integrity. When a cell mis-segregates a single chromosome, it doesn't always die. It survives as a metabolic parasite, triggering a proteostatic overload that eventually shows up as a patient's first chronic disease.

I suspect the difference between a healthspan that ends at sixty and one that lasts until ninety isn’t just lifestyle—it’s a localized collapse of mitotic fidelity in specific stem cell niches. If your vascular endothelium loses its SAC efficiency five years before your neurons do, you get heart disease. Swap them, and you get dementia. The "first disease" is simply the first tissue to hit its structural error threshold.

We need a Human Fidelity Atlas. Right now, we’re flying blind. We need the funding and the experts to perform high-throughput, live-cell lattice lightsheet imaging on primary human tissues across a fifty-year age span. We need to quantify the friction of the kinetochore-microtubule interface in vivo. We need to know which SAC proteins are the first to undergo age-related phase separation or degradation.

If we can identify the molecular weak points where mitotic fidelity first breaks down, we can move from reactive geriatrics to proactive kinetic shoring. We could potentially reinforce the kinetochore scaffold before the first aneuploid event ever triggers a senescent cascade. We’re currently measuring the fire once the house is half-gone. Let’s start measuring the heat of the friction before the spark even flies.